Medco buys Polymedica for $1.5B
Medco Health Solutions hopes that what's good for diabetes patients is also good for its bottom line. The company has agreed to pay $1.5 billion to acquire PolyMedica, the nation's largest supplier of blood-glucose testing supplies and other diabetes-related services.
The two companies already have been working together; Medco fills some 50,000 scrips a week for PolyMedica patients, and Polymedica has offered testing supplies and Medicare Part B management services to some Medco clients. The companies say the deal creates "the nation's most advanced large-scale practice focused on diabetes care."
Medco will pay $53 per share for PolyMedica, which closed Monday at $45.29. Together, the two companies will serve some 3.8 million diabetes patients.
- read the CNN report on the deal
Related Articles:
Diabetes epidemic triggers soaring drug market. Report
Medco reaches settlement with DOJ. Report
Medco to launch e-prescribing study with CMS. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
